Karuna Therapeutics Inc (KRTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Steven M. Paul
Employees:
120
33 ARCH STREET SUITE 3110 BOSTON MA 02110

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia.

Data derived from most recent annual or quarterly report
Market Cap 6.242 Billion Shares Outstanding34.363 Million Avg 30-day Volume 592.638 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-8.74
Price to Revenue103.268 Debt to Equity0.0 EBITDA-142.732 Million
Price to Book Value7.6036 Operating Margin-389.1705 Enterprise Value3.323 Billion
Current Ratio25.594 EPS Growth-0.907 Quick Ratio24.526
1 Yr BETA 1.1047 52-week High/Low 278.25 / 92.26 Profit Margin-389.0407
Operating Cash Flow Growth-44.4085 Altman Z-Score88.8429 Free Cash Flow to Firm -92.131 Million
Earnings Report2023-05-04
View SEC Filings from KRTX instead.

View recent insider trading info

Karuna Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding KRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KRTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-09 by BRANNAN STEPHEN K.
  • 4: filed on 2023-02-23 by IGNELZI TROY A.
  • 4: filed on 2023-02-13 by IGNELZI TROY A.
  • 4: filed on 2023-02-13 by BRANNAN STEPHEN K.
  • 4: filed on 2023-02-13 by Miller Andrew Craig
  • 4: filed on 2023-02-13 by PAUL STEVEN M
  • 4: filed on 2023-02-07 by KANE WILLIAM P JR
  • 3: filed on 2023-02-07 by KANE WILLIAM P JR
  • 4: filed on 2023-01-19 by IGNELZI TROY A.
  • 4: filed on 2023-01-09 by BRANNAN STEPHEN K.

    • Events (8k)

  • 8-K: filed on 2023-03-22:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-20:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-10:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-02-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-11:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    16 Thousand total shares from 3 transactions

    Exercise Derivative Conversion (M)

    16 Thousand total shares from 3 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BRANNAN STEPHEN K. CHIEF MEDICAL OFFICER

    • Officer
    		 23,650 2023-03-09 11

    IGNELZI TROY A. CHIEF FINANCIAL OFFICER

    • Officer
    		 30,487 2023-02-21 8

    PAUL STEVEN M CSO AND PRESIDENT OF R&D

    • Officer
    • Director
    		 120,249 2023-02-09 1

    MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

    • Officer
    		 30,900 2023-02-09 5

    KANE WILLIAM P JR CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2023-02-06 2

    HEALY JAMES

    • Director
    		 1,811,651 2023-01-12 4

    COUGHLIN CHRISTOPHER J

    • Director
    		 976 2023-01-03 2

    MEURY WILLIAM PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2023-01-03 2

    OLSON LAURIE J

    • Director
    		 15,000 2023-01-03 6

    JONAS JEFFREY M

    • Director
    		 5,000 2022-06-15 1

    PANDE ATUL

    • Director
    		 5,000 2022-06-15 1

    WHEADON DAVID E.

    • Director
    		 5,000 2022-06-15 1

    TORRES DENICE

    • Director
    		 5,000 2022-06-15 1

    LYKINS CHARMAINE CHIEF COMMERCIAL OFFICER

    • Officer
    		 75,000 2021-11-29 0

    PRESTON HEATHER

    • Director
    		 6,556 2021-06-24 0

    ARCH VENTURE PARTNERS IX, LLC

    ARCH VENTURE PARTNERS IX, L.P.

    ARCH VENTURE PARTNERS IX OVERAGE, L.P.

    ARCH VENTURE FUND IX, L.P.

    ARCH VENTURE FUND IX OVERAGE, L.P.

    BYBEE CLINTON

    CRANDELL KEITH

    • 10% Owner
    		 No longer subject to file 2021-04-13 0

    NELSEN ROBERT

    • Director
    • 10% Owner
    		 2,918,141 2021-04-13 0

    PURETECH HEALTH LLC

    • FORMER 10% OWNER
    		 No longer subject to file 2021-02-09 0

    HARRIGAN EDMUND

    • Director
    		 55,163 2020-08-12 0

    ALEXANDRIA VENTURE INVESTMENTS, LLC

    • 10% Owner
    		 No longer subject to file 2019-07-02 0

    CHOWRIRA BHARAT M

    • Director
    		 10,000 2019-07-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BRANNAN STEPHEN K. - Officer CHIEF MEDICAL OFFICER

    		2023-03-09 17:12:40 -0500 2023-03-09 M 5,000 d 24,677 direct

    BRANNAN STEPHEN K. - Officer CHIEF MEDICAL OFFICER

    		2023-03-09 17:12:40 -0500 2023-03-09 S 5,000 $189.51 d 23,650 direct yes 3.1999 7.014 7.014 6 0.0 1

    BRANNAN STEPHEN K. - Officer CHIEF MEDICAL OFFICER

    		2023-03-09 17:12:40 -0500 2023-03-09 M 5,000 $5.45 a 28,650 direct 3.1999 7.014 7.014 6 0.0 1

    IGNELZI TROY A. - Officer CHIEF FINANCIAL OFFICER

    		2023-02-23 16:37:23 -0500 2023-02-21 M 6,000 d 103,726 direct

    IGNELZI TROY A. - Officer CHIEF FINANCIAL OFFICER

    		2023-02-23 16:37:23 -0500 2023-02-21 S 6,000 $190.01 d 30,487 direct yes -0.2225 -1.1378 0.8445 3 -1.2086 5

    IGNELZI TROY A. - Officer CHIEF FINANCIAL OFFICER

    		2023-02-23 16:37:23 -0500 2023-02-21 M 6,000 $9.20 a 36,487 direct -0.2225 -1.1378 0.8445 3 -1.2086 5

    IGNELZI TROY A. - Officer CHIEF FINANCIAL OFFICER

    		2023-02-13 16:39:38 -0500 2023-02-09 A 8,650 a 30,487 direct 0.6063 -1.4872 -6.4048 3.3371 10 -16.4007 25

    MILLER ANDREW CRAIG - Officer CHIEF OPERATING OFFICER

    		2023-02-13 16:33:11 -0500 2023-02-09 A 25,100 a 25,100 direct

    MILLER ANDREW CRAIG - Officer CHIEF OPERATING OFFICER

    		2023-02-13 16:33:11 -0500 2023-02-09 A 12,550 a 30,900 direct 0.6063 -1.4872 -6.4048 3.3371 10 -16.4007 25

    IGNELZI TROY A. - Officer CHIEF FINANCIAL OFFICER

    		2023-02-13 16:39:38 -0500 2023-02-09 A 17,350 a 17,350 direct

    BRANNAN STEPHEN K. - Officer CHIEF MEDICAL OFFICER

    		2023-02-13 16:36:18 -0500 2023-02-09 A 17,350 a 17,350 direct

    BRANNAN STEPHEN K. - Officer CHIEF MEDICAL OFFICER

    		2023-02-13 16:36:18 -0500 2023-02-09 A 8,650 a 23,650 direct 0.6063 -1.4872 -6.4048 3.3371 10 -16.4007 25

    BRANNAN STEPHEN K. - Officer CHIEF MEDICAL OFFICER

    		2023-02-13 16:36:18 -0500 2023-02-09 M 5,000 d 29,677 direct

    BRANNAN STEPHEN K. - Officer CHIEF MEDICAL OFFICER

    		2023-02-13 16:36:18 -0500 2023-02-09 S 5,000 $192.37 d 15,000 direct yes 0.6063 -1.4872 -6.4048 3.3371 10 -16.4007 25

    BRANNAN STEPHEN K. - Officer CHIEF MEDICAL OFFICER

    		2023-02-13 16:36:18 -0500 2023-02-09 M 5,000 $5.45 a 20,000 direct 0.6063 -1.4872 -6.4048 3.3371 10 -16.4007 25

    PAUL STEVEN M - Director - Officer CSO AND PRESIDENT OF R&D

    		2023-02-13 16:15:43 -0500 2023-02-09 A 22,800 a 22,800 direct

    PAUL STEVEN M - Director - Officer CSO AND PRESIDENT OF R&D

    		2023-02-13 16:15:43 -0500 2023-02-09 A 11,400 a 11,400 direct 0.6063 -1.4872 -6.4048 3.3371 10 -16.4007 25

    KANE WILLIAM P JR - Officer CHIEF COMMERCIAL OFFICER

    		2023-02-07 18:16:51 -0500 2023-02-06 A 17,656 a 17,656 direct -3.4045 0.1496 -9.0994 2.868 14 -16.7802 29

    KANE WILLIAM P JR - Officer CHIEF COMMERCIAL OFFICER

    		2023-02-07 18:16:51 -0500 2023-02-06 A 29,937 a 29,937 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 22:15:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 21:45:05 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 21:15:03 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 20:45:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 20:15:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 19:45:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 19:15:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 18:45:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 18:15:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 17:45:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 17:15:03 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 16:45:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 16:15:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 15:45:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 15:15:03 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 14:45:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 14:15:04 UTC 4.57 0.25 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 13:45:03 UTC 4.5432 0.2768 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 13:15:03 UTC 4.5432 0.2768 500000
    KARUNA THERAPEUTICS INC KRTX 2023-03-31 12:45:03 UTC 4.5432 0.2768 500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund KRTX -11.0 shares, $-792.0 2020-03-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund KRTX -6.0 shares, $-463.92 2020-09-30 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund KRTX -11.0 shares, $-792.0 2020-03-31 N-PORT
    WASATCH FUNDS TRUST- Wasatch Long/Short Alpha Fund KRTX -833.0 shares, $-163684.5 2022-12-31 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund KRTX -373.0 shares, $-73294.5 2022-12-30 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Strategic Equity Fund KRTX -356.0 shares, $-69954.0 2022-12-31 N-PORT
    RUSSELL INVESTMENT CO- U.S. Strategic Equity Fund KRTX -2321.0 shares, $-462784.19 2023-01-31 N-PORT
    RUSSELL INVESTMENT CO- Sustainable Equity Fund KRTX -84.0 shares, $-16748.76 2023-01-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments